Session information

Symposium

[S-40] Symposium 40 Dyskinesia in Parkinson's Disease: Filling the Bedside-to-Bench Gap

Sat. May 22, 2021 8:00 AM - 10:00 AM Room 04 (ICC Kyoto 2F Room A)

Chair：Tomiyama Masahiko(Department of Neurology, Hirosaki University Graduate School of Medicine),Yamakado Hodaka(Kyoto University Hospital)

Participants should be better able to:(1) review the clinical aspects of dyskinesias in Parkinson’s disease. (2) know changes of basal ganglia cirduit functions in hyperkinetic disorders. (3)become well-informed on evidence that dyskinesias relate to pathogogical maladaptive changes in basal ganglia. (4).evaluate the mechanisms by which glutamate and serotonin receptors can modulate an altered dopamine signaling in dyskinesias and refer to implication for drug treatment.

+Add all to schedule

[S-40-1] Update on the Clinical Phenomenology, Risk Factors and Burden of Dyskinesias

^○Atsushi Takeda^1,2 (1.Department of Neurology, National Hospital Organization Sendai-Nishitaga Hospital, Japan, 2.Department of motor and cognitive aging, Tohoku university graduate school of medicine, Japan)

[S-40-2] External and internal loops of the basal ganglia (BG)

^○Yoshikazu Ugawa (Department of Human Neurophysiology, Japan)

[S-40-3] Morphological and Functional Changes of Striatal Neurons in Dyskinesia

^○Haruo Nishijima (Department of Neurology, Hirosaki University Hospital, Japan)

[S-40-4] Future medical treatments for dyskinesias: from bench to bedside

^○M. Angela Cenci^1,2 (1.Lund University, Dept. Experimental Medical Science, Basal Ganglia Pathophysiology, Lund (Sweden), Sweden, 2.Wallenberg Neuroscience Centre, Sweden)

▲